JP3081359B2 - 2-amino-1-phenyl-1-ethanol derivative - Google Patents

2-amino-1-phenyl-1-ethanol derivative

Info

Publication number
JP3081359B2
JP3081359B2 JP04109081A JP10908192A JP3081359B2 JP 3081359 B2 JP3081359 B2 JP 3081359B2 JP 04109081 A JP04109081 A JP 04109081A JP 10908192 A JP10908192 A JP 10908192A JP 3081359 B2 JP3081359 B2 JP 3081359B2
Authority
JP
Japan
Prior art keywords
ethanol
ethyl
reaction
chlorophenyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP04109081A
Other languages
Japanese (ja)
Other versions
JPH05286908A (en
Inventor
正 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kohjin Holdings Co Ltd
Original Assignee
Kohjin Holdings Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kohjin Holdings Co Ltd filed Critical Kohjin Holdings Co Ltd
Priority to JP04109081A priority Critical patent/JP3081359B2/en
Publication of JPH05286908A publication Critical patent/JPH05286908A/en
Application granted granted Critical
Publication of JP3081359B2 publication Critical patent/JP3081359B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、化2(式中、R1 は水
素原子またはアセチル基、R2 は水素原子または低級ア
ルキル基、Xは塩素原子または臭素原子、YはNR3
(R3 は低級アルキル基、またはシアノ基を表す。)ま
たはCH−NO2 基を表す。)で表される文献未記載の
2−アミノ−1−フェニル−1−エタノール誘導体に関
する。
The present invention relates to a compound represented by the formula (2) wherein R 1 is a hydrogen atom or an acetyl group, R 2 is a hydrogen atom or a lower alkyl group, X is a chlorine atom or a bromine atom, and Y is an NR 3 group ( R 3 relates to a lower alkyl group or a cyano group.) or 2-amino-1-phenyl-1-ethanol derivatives not disclosed in any literature represented by representative.) the CH-NO 2 group.

【化2】 これら化合物は抗潰瘍作用を有し、消化管における潰瘍
の予防、治療に有用である。
Embedded image These compounds have an anti-ulcer effect and are useful for the prevention and treatment of ulcers in the gastrointestinal tract.

【0002】[0002]

【従来の技術】従来、抗消化性潰瘍剤としては攻撃因子
抑制型又は防御因子増強型に大別され各種誘導体が知ら
れている。一般に攻撃因子抑制型の誘導体は著効をしめ
すが、種々の副作用を有し、リバウンドにより潰瘍の再
発をまねくという欠点があり、一方防御因子増強型の誘
導体は遅効性であり、かつ効果も満足いくものでなかっ
た。
2. Description of the Related Art Hitherto, various derivatives have been known as anti-peptic ulcers which are roughly classified into aggressive factor suppressing type and protective factor enhancing type. In general, aggressive factor-suppressing derivatives are very effective, but have various side effects and have the disadvantage of causing relapse of ulcers due to rebound.On the other hand, protective factor-enhancing derivatives are slow-acting and have satisfactory effects. It didn't work.

【0003】[0003]

【発明が解決しようとする課題】安全性が高く、すみや
かにかつ優れた効果を発揮する抗消化性潰瘍剤の開発が
望まれている。
There is a demand for the development of an anti-peptic ulcer agent which is highly safe, promptly and exhibits excellent effects.

【0004】[0004]

【課題を解決するための手段】本発明者等は、かかる課
題を解決するため鋭意研究の結果、化2(式中、R1
水素原子またはアセチル基、R2 は水素原子または低級
アルキル基、Xは塩素原子または臭素原子、YはNR3
基(R3 は低級アルキル基、またはシアノ基を表す。)
またはCH−NO2 基を表す。)で表される文献未記載
の2−アミノ−1−フェニル−1−エタノール誘導体
が、優れた抗消化性潰瘍作用を有していることを見いだ
し、本発明を完成するに至った。本明細書中、低級アル
キル基はメチル基、エチル基又はプロピル基を意味す
る。
The present inventors have SUMMARY OF THE INVENTION As a result of intensive studies for solving the above problems, of 2 (wherein, R 1 represents a hydrogen atom or an acetyl group, R 2 is a hydrogen atom or a lower alkyl group , X is a chlorine atom or a bromine atom, Y is NR 3
Group (R 3 represents a lower alkyl group or a cyano group)
Or a CH-NO 2 group. The present inventors have found that a 2-amino-1-phenyl-1-ethanol derivative described in the literature, which has not been described in the literature, has an excellent antipeptic ulcer effect, and completed the present invention. In the present specification, a lower alkyl group means a methyl group, an ethyl group or a propyl group.

【0005】上記化2で表される化合物は種々の方法で
合成可能である。例えば、化3(式中、Xは塩素原子ま
たは臭素原子を表す。)で表されるアミノアルコール誘
導体と、式CH3S−C(=Y)−SCH3(式中、Yは
NR3 基(R3 は低級アルキル基、またはシアノ基を表
す。)またはCH−NO2 基を表す。)で表される化合
物とを反応させることにより化4(式中、X、Yは前記
と同じ。)の化合物に変換し、ついでこれを式NH22
(式中、R2 は、水素原子または低級アルキル基を表
す。)で表されるアミンまたはアンモニア水と反応させ
ることにより化5(式中、X、Y、R2 は前記と同
じ。)の誘導体を合成することができる。
The compound represented by the above formula (2) can be synthesized by various methods. For example, an amino alcohol derivative represented by the formula 3 (wherein X represents a chlorine atom or a bromine atom) and a formula CH 3 SC (= Y) -SCH 3 (where Y is an NR 3 group (Wherein R 3 represents a lower alkyl group or a cyano group) or a CH—NO 2 group) by reacting with a compound represented by the formula (wherein X and Y are the same as described above). ), Which is then converted to a compound of the formula NH 2 R 2
(Wherein R 2 represents a hydrogen atom or a lower alkyl group) by reacting with an amine represented by the following formula (5) (wherein X, Y and R 2 are the same as above). Derivatives can be synthesized.

【化3】 Embedded image

【化4】 Embedded image

【化5】 Embedded image

【0006】化3で表されるアミノアルコールより化4
で表される化合物への変換は溶媒の存在下実施される。
使用される溶媒としては反応を阻害しないもので適当で
あるが、アルコール、アセトニトリル、水、あるいはこ
れらの混合溶媒が好ましく、反応温度は0℃から溶媒の
沸点の範囲、反応時間は、反応条件にもよるが1時間か
ら24時間程度である。反応生成物は、反応終了後析出
した結晶を濾取することにより、あるいは溶媒を留去
後、適当な溶媒、例えばエタノール、エタノール−石油
エーテル等より結晶化する事により単離される。
The amino alcohol represented by Chemical Formula 3 is converted to Chemical Formula 4
Is carried out in the presence of a solvent.
As the solvent used, any solvent that does not inhibit the reaction is suitable, but alcohol, acetonitrile, water, or a mixed solvent thereof is preferable.The reaction temperature ranges from 0 ° C. to the boiling point of the solvent, and the reaction time depends on the reaction conditions. Depending on the case, it is about 1 hour to 24 hours. The reaction product is isolated by filtering the precipitated crystals after completion of the reaction, or by distilling off the solvent and then crystallization from an appropriate solvent such as ethanol, ethanol-petroleum ether or the like.

【0007】ついで化5で表される化合物への変換は、
溶媒中アミンと反応させることにより実施される。使用
される溶媒としては反応を阻害しないもので適当である
が、アルコール、水、あるいはこれらの混合溶媒が好ま
しく、過剰のアミンを溶媒として用いてもよい。反応温
度は室温から溶媒の沸点の範囲、反応時間は1〜10時
間程度である。反応生成物は、反応終了後溶媒を留去
し、残渣を適当な溶媒、例えばエタノール、エタノール
−水等より結晶化する事により単離される。
Next, the conversion into the compound represented by the formula (5)
It is carried out by reacting with an amine in a solvent. As the solvent to be used, any solvent that does not inhibit the reaction is suitable, but alcohol, water, or a mixed solvent thereof is preferable, and an excess of amine may be used as the solvent. The reaction temperature ranges from room temperature to the boiling point of the solvent, and the reaction time is about 1 to 10 hours. The reaction product is isolated by distilling off the solvent after completion of the reaction and crystallizing the residue from an appropriate solvent, for example, ethanol, ethanol-water or the like.

【0008】化5で表される化合物は、化3で表される
アミノアルコールと、式CH3 S−C(=Y)−NHR
2 (式中、Y、R2 は前記と同じ。)で表される化合物
とを反応させることにより合成することもできる。反応
は溶媒の存在下実施され、例えば好適な溶媒としてアル
コール、アセトン、水等が挙げられ、反応系中にアルカ
リを存在させてもよい。反応温度は室温から溶媒の沸点
の範囲、反応時間は1〜10時間程度である。反応生成
物は、反応終了後溶媒を留去し、残渣を適当な溶媒、例
えばエタノール、エタノール−水等より結晶化する事に
より単離される。
The compound represented by the formula (5) is obtained by combining the amino alcohol represented by the formula ( 3 ) with a compound of the formula CH 3 SC (= Y) -NHR
2 (wherein, Y and R 2 are the same as described above). The reaction is carried out in the presence of a solvent, for example, suitable solvents include alcohol, acetone, water and the like, and an alkali may be present in the reaction system. The reaction temperature ranges from room temperature to the boiling point of the solvent, and the reaction time is about 1 to 10 hours. The reaction product is isolated by distilling off the solvent after completion of the reaction and crystallizing the residue from an appropriate solvent, for example, ethanol, ethanol-water or the like.

【0009】化5で表される化合物はまた、例えば特開
昭64−52749号に開示されている下記化6(式
中、X、R2 は前記と同じ。)で表される化合物をヨウ
化メチルと反応しイソチオウレア誘導体とし、ついで式
NH23 (式中、R3は前記と同じ。)で表されるアミ
ンと反応することによっても合成することができる。
The compound represented by the formula (5) may be a compound represented by the following formula (6) wherein X and R 2 are the same as those disclosed in JP-A-64-52749. By reacting with methyl chloride to form an isothiourea derivative, and then reacting with an amine represented by the formula NH 2 R 3 (wherein R 3 is the same as described above).

【化6】 Embedded image

【0010】化5で表される化合物から化7(式中、R
1 はアセチル基を表し、X、Y、R2 は前記と同じ。)
で表される化合物への変換は、無水酢酸と反応させるこ
とにより合成される。
From the compound represented by the formula (5), the compound represented by the formula (7)
1 represents an acetyl group, X, Y, R 2 are as defined above. )
Is synthesized by reacting with acetic anhydride.

【化7】 反応は直接無水酢酸と反応させてもよく、またピリジン
等の塩基存在下反応を実施してもよい。反応温度は0℃
〜溶媒の沸点の範囲、反応時間は1〜3時間程度で十分
である。反応生成物は、反応終了後析出した結晶を濾取
することにより、あるいは溶媒を留去後、適当な溶媒、
例えばエタノール、エタノール−水等より結晶化する事
により単離される。
Embedded image The reaction may be carried out directly with acetic anhydride or may be carried out in the presence of a base such as pyridine. Reaction temperature is 0 ° C
The range of the boiling point of the solvent and the reaction time of about 1 to 3 hours are sufficient. The reaction product is obtained by filtering the precipitated crystals after completion of the reaction, or after distilling off the solvent, an appropriate solvent,
For example, it is isolated by crystallization from ethanol, ethanol-water, or the like.

【0011】[0011]

【実施例】以下、実施例を挙げて本発明を詳細に説明す
る。 実施例 1 本発明化合物の評価例(水浸拘束ストレス潰瘍) Wistar系のラット(オス:体重150〜200g)を2
4時間絶食後、被験薬(10mg/5ml/kg)及び
対照溶媒を経口投与し、直ちにストレスゲージに入れ不
動化し、22℃の水槽内に剣状突起の深さまで浸し、ス
トレスを負荷した。7時間後にラットを殺し全胃を摘出
して2%ホルマリン液を12.5ml胃内に注入し、2
%ホルマリン液中に10分間浸した。胃は大彎に沿って
切開し腺胃部に発生した潰瘍の長さをノギスにより測定
し潰瘍係数とし、対照溶媒の潰瘍係数と比較し抑制率を
求めた。(1群6〜10匹)結果を表1に示す。
The present invention will be described below in detail with reference to examples. Example 1 Evaluation Example of Compound of the Present Invention (Water Immersion Stress Ulcer) Two Wistar rats (male: body weight 150 to 200 g) were used.
After a 4-hour fast, the test drug (10 mg / 5 ml / kg) and a control solvent were orally administered, immobilized immediately in a stress gauge, and immersed in a water bath at 22 ° C. to the depth of the xiphoid process to apply stress. Seven hours later, the rat was killed, the whole stomach was removed, and 12.5 ml of 2% formalin solution was injected into the stomach.
% Formalin solution for 10 minutes. The stomach was incised along the greater curvature and the length of the ulcer generated in the glandular stomach was measured with a caliper to determine the ulcer index, which was compared with the ulcer index of the control solvent to determine the inhibition rate. (6 to 10 animals per group) The results are shown in Table 1.

【表1】 [Table 1]

【0012】実施例 2 エタノール25mlにα−アミノメチル−p−クロロベ
ンジルアルコール3.8gとS,S’−ジメチル−N−
シアノジチオイミノカーボネイト2.9gを溶解し、室
温で3時間攪拌した。反応終了後冷蔵庫に一晩放置し、
析出した結晶を濾取することにより、中間体、N−シア
ノ−N’−[2−ヒドロキシ−2−(p−クロロフェニ
ル)エチル]−S−メチルイソチオウレア4.1gを得
た。 実施例 3 N−シアノ−N’−[2−ヒドロキシ−2−(p−クロ
ロフェニル)エチル]−S−メチルイソチオウレア3g
をエタノール20mlに懸濁し、攪拌下メチルアミン4
0%メタノール溶液20mlを加え室温3時間攪拌し
た。反応終了後減圧下溶媒を留去し、残渣をエタノール
−石油エーテルより結晶化することによりN−シアノ−
N’−メチル−N”−[2−ヒドロキシ−2−(p−ク
ロロフェニル)エチル]グアニジン2.6gを得た。
融点 139〜42℃ TLC Rf=0.45 (CHCl3ーMeOH=9:1) 元素分析値 (C1113ClN4Oとして) 計算値 (%) C: 52.28% H: 5.18% N: 22.17% 測定値 (%) C: 52.44% H: 5.25% N: 22.03% 赤外線吸収スペクトル 2160cm-1 (CN) 実施例 4 実施例3においてメチルアミン40%メタノール溶液2
0mlに代えてエチルアミン70%溶液10mlを用い
同様に処理することによりN−シアノ−N’−エチル−
N”−[2−ヒドロキシ−2−(p−クロロフェニル)
エチル]グアニジン2.4gを得た。 TLC Rf=0.57 (CHCl3ーMeOH=9:1) 実施例 5 実施例3においてメチルアミン40%メタノール溶液2
0mlに代えて濃アンモニア水20mlを用い同様に処
理し、エタノール−水より結晶化することによりN−シ
アノ−N’−[2−ヒドロキシ−2−(p−クロロフェ
ニル)エチル]グアニジン1.3gを得た。 TLC Rf=0.28 (CHCl3ーMeOH=9:1)
Example 2 3.8 g of α-aminomethyl-p-chlorobenzyl alcohol and 25% of S, S′-dimethyl-N-ethanol were added to 25 ml of ethanol.
2.9 g of cyanodithioiminocarbonate was dissolved and stirred at room temperature for 3 hours. After the reaction, leave it in the refrigerator overnight,
The precipitated crystals were collected by filtration to obtain 4.1 g of an intermediate, N-cyano-N '-[2-hydroxy-2- (p-chlorophenyl) ethyl] -S-methylisothiourea. Example 3 3 g of N-cyano-N '-[2-hydroxy-2- (p-chlorophenyl) ethyl] -S-methylisothiourea
Is suspended in 20 ml of ethanol, and methylamine 4 is stirred under stirring.
20 ml of a 0% methanol solution was added, and the mixture was stirred at room temperature for 3 hours. After completion of the reaction, the solvent was distilled off under reduced pressure, and the residue was crystallized from ethanol-petroleum ether to give N-cyano-
2.6 g of N′-methyl-N ″-[2-hydroxy-2- (p-chlorophenyl) ethyl] guanidine were obtained.
139-42 ° C TLC Rf = 0.45 (CHCl 3 -MeOH = 9: 1) Elemental analysis (as C 11 H 13 ClN 4 O) Calculated (%) C: 52.28% H: 5.18% N: 22.17 % Measured value (%) C: 52.44% H: 5.25% N: 22.03% Infrared absorption spectrum 2160 cm -1 (CN) Example 4 Methylamine 40% methanol solution 2 in Example 3
The same treatment was carried out using 10 ml of a 70% solution of ethylamine instead of 0 ml to obtain N-cyano-N′-ethyl-.
N "-[2-hydroxy-2- (p-chlorophenyl)
2.4 g of [ethyl] guanidine were obtained. TLC Rf = 0.57 (CHCl 3 -MeOH = 9: 1) Example 5 Methylamine 40% methanol solution 2 in Example 3
The same treatment was carried out using 20 ml of concentrated ammonia water instead of 0 ml, and crystallization from ethanol-water gave 1.3 g of N-cyano-N ′-[2-hydroxy-2- (p-chlorophenyl) ethyl] guanidine. Obtained. TLC Rf = 0.28 (CHCl 3 -MeOH = 9: 1)

【0013】実施例 6 N−メチル−N’−[2−ヒドロキシ−2−(p−クロ
ロフェニル)エチル]−チオウレア2.5gをメタノー
ル30mlに溶解し、ヨウ化メチル1.42gを加え2
時間攪拌下還流した。反応後、減圧下濃縮し、残渣をエ
タノール20mlに溶解し、攪拌下メチルアミン40%
メタノール溶液20mlを加え、室温3時間、50℃5
時間攪拌した。反応終了後、減圧下濃縮し残渣をエタノ
ールから結晶化することにより、N,N’−ジメチル−
N”−[2−ヒドロキシ−2−(p−クロロフェニル)
エチル]グアニジン1.5gを得た。 融点 199〜201℃ TLC Rf=0.24 (CHCl3ーMeOH=9:1) 元素分析値 (C1116ClN3Oとして) 計算値 (%) C: 54.66% H: 6.67% N: 17.38% 測定値 (%) C: 54.81% H: 6.83% N: 17.11% 実施例 7 実施例6においてN−メチル−N’−[2−ヒドロキシ
−2−(p−クロロフェニル)エチル]−チオウレアに
代えてN−エチル−N’−[2−ヒドロキシ−2−(p
−クロロフェニル)エチル]−チオウレア2.6gを用
い同様に処理し、エタノール−エーテルより結晶化する
ことによりN−エチル−N’−メチル−N”−[2−ヒ
ドロキシ−2−(p−クロロフェニル)エチル]グアニ
ジン1.3gを得た。 融点 137〜8℃ TLC Rf=0.30 (CHCl3ーMeOH=9:1)
Example 6 2.5 g of N-methyl-N '-[2-hydroxy-2- (p-chlorophenyl) ethyl] -thiourea was dissolved in 30 ml of methanol, and 1.42 g of methyl iodide was added.
The mixture was refluxed under stirring for an hour. After the reaction, the mixture was concentrated under reduced pressure, and the residue was dissolved in 20 ml of ethanol.
Add methanol solution (20 ml), room temperature for 3 hours,
Stirred for hours. After completion of the reaction, the mixture is concentrated under reduced pressure, and the residue is crystallized from ethanol to give N, N'-dimethyl-.
N "-[2-hydroxy-2- (p-chlorophenyl)
1.5 g of [ethyl] guanidine were obtained. Melting point 199-201 ° C TLC Rf = 0.24 (CHCl 3 -MeOH = 9: 1) Elemental analysis (as C 11 H 16 ClN 3 O) Calculated (%) C: 54.66% H: 6.67% N: 17.38 % Measured value (%) C: 54.81% H: 6.83% N: 17.11% Example 7 In Example 6, N-methyl-N ′-[2-hydroxy-2- (p-chlorophenyl) ethyl] -thiourea was used instead. N-ethyl-N ′-[2-hydroxy-2- (p
-Chlorophenyl) ethyl] -thiourea and 2.6 g of N-ethyl-N′-methyl-N ″-[2-hydroxy-2- (p-chlorophenyl) by crystallization from ethanol-ether 1.3 g of ethyl] guanidine Melting point 137-8 ° C. TLC Rf = 0.30 (CHCl 3 -MeOH = 9: 1)

【0014】実施例 8 エタノール50mlにα−アミノメチル−p−クロロベ
ンジルアルコール6.9gと1,1−ビス(メチルチ
オ)−2−ニトロエチレン6.6gを加え、60〜70
℃で5時間攪拌した。反応終了後、減圧下濃縮し残渣を
エタノール−石油エーテルから結晶化することにより、
中間体、N−[2−ヒドロキシ−2−(p−クロロフェ
ニル)エチル]−1−メチルチオ−2−ニトロエテンア
ミン8.3gを得た。 実施例 9 N−[2−ヒドロキシ−2−(p−クロロフェニル)エ
チル]−1−メチルチオ−2−ニトロエテンアミン2g
をエタノール20mlに懸濁し、攪拌下メチルアミン4
0%メタノール溶液15mlを加え、70℃終夜攪拌し
た。反応終了後減圧下濃縮し、残渣をエタノールから結
晶化することにより、N−[2−ヒドロキシ−2−(p
−クロロフェニル)エチル]−N’−メチル−2−ニト
ロ−1,1−エテンジアミン0.92gを得た。 融点
175〜6℃ TLC Rf=0.29 (CHCl3ーMeOH=9:1) 元素分析値 (C1114ClN33として) 計算値 (%) C: 48.63% H: 5.19% N: 15.47% 測定値 (%) C: 48.79% H: 5.32% N: 15.36% 実施例10 実施例9においてメチルアミン40%メタノール溶液1
5mlに代えてエチルアミン70%溶液10mlを用い
同様に処理し、エタノール−石油エーテルより結晶化す
ることにより、N−[2−ヒドロキシ−2−(p−クロ
ロフェニル)エチル]−N’−エチル−2−ニトロ−
1,1−エテンジアミン1.5gを得た。 融点 136〜9℃ TLC Rf=0.40 (CHCl3ーMeOH=9:1) 実施例11 N−[2−ヒドロキシ−2−(p−クロロフェニル)エ
チル]−1−メチルチオ−2−ニトロエテンアミン2g
をエタノール20mlに懸濁し、攪拌下濃アンモニア水
を加え、室温3時間、70℃5時間攪拌した。反応終了
後減圧下濃縮し、残渣に1N塩酸を加え抽出、アルカリ
で中和後冷蔵庫に一晩放置し、析出した結晶を濾取する
ことにより、N−[2−ヒドロキシ−2−(p−クロロ
フェニル)エチル]−2−ニトロ−1,1−エテンジア
ミン0.83gを得た。 融点 188〜9℃ TLC Rf=0.14 (CHCl3ーMeOH=9:1)
Example 8 To 50 ml of ethanol, 6.9 g of α-aminomethyl-p-chlorobenzyl alcohol and 6.6 g of 1,1-bis (methylthio) -2-nitroethylene were added,
Stirred at C for 5 hours. After completion of the reaction, the mixture was concentrated under reduced pressure, and the residue was crystallized from ethanol-petroleum ether.
8.3 g of the intermediate, N- [2-hydroxy-2- (p-chlorophenyl) ethyl] -1-methylthio-2-nitroethenamine, were obtained. Example 9 2 g of N- [2-hydroxy-2- (p-chlorophenyl) ethyl] -1-methylthio-2-nitroethenamine
Is suspended in 20 ml of ethanol, and methylamine 4 is stirred under stirring.
15 ml of a 0% methanol solution was added, and the mixture was stirred at 70 ° C. overnight. After completion of the reaction, the mixture was concentrated under reduced pressure, and the residue was crystallized from ethanol to give N- [2-hydroxy-2- (p
-Chlorophenyl) ethyl] -N'-methyl-2-nitro-1,1-ethenediamine 0.92 g was obtained. Melting point 175-6 ° C TLC Rf = 0.29 (CHCl 3 -MeOH = 9: 1) Elemental analysis (as C 11 H 14 ClN 3 O 3 ) Calculated (%) C: 48.63% H: 5.19% N: 15.47% measured value (%) C: 48.79% H: 5.32% N: 15.36% Example 10 In Example 9, methylamine 40% methanol solution 1
The same treatment was carried out using 10 ml of a 70% ethylamine solution instead of 5 ml, and crystallization from ethanol-petroleum ether gave N- [2-hydroxy-2- (p-chlorophenyl) ethyl] -N′-ethyl-2. -Nitro-
1.5 g of 1,1-ethenediamine was obtained. Mp 136~9 ℃ TLC Rf = 0.40 (CHCl 3 over MeOH = 9: 1) Example 11 N-[2-hydroxy-2- (p-chlorophenyl) ethyl] -1-methylthio-2-nitro ethene amine 2g
Was suspended in 20 ml of ethanol, concentrated aqueous ammonia was added with stirring, and the mixture was stirred at room temperature for 3 hours and at 70 ° C. for 5 hours. After completion of the reaction, the reaction mixture was concentrated under reduced pressure, 1N hydrochloric acid was added to the residue, extracted, neutralized with alkali, left standing in a refrigerator overnight, and the precipitated crystals were collected by filtration to give N- [2-hydroxy-2- (p- 0.83 g of [chlorophenyl) ethyl] -2-nitro-1,1-ethenediamine were obtained. Melting point 188-9 ° C TLC Rf = 0.14 (CHCl 3 -MeOH = 9: 1)

【0015】実施例12 エタノール25mlにα−アミノメチル−p−ブロモベ
ンジルアルコール4.3gとS,S’−ジメチル−N−
シアノジチオイミノカーボネイト2.9gを溶解し、室
温で3時間攪拌した。反応終了後冷蔵庫に一晩放置し、
析出した結晶を濾取することにより、中間体、N−シア
ノ−N’−[2−ヒドロキシ−2−(p−ブロモフェニ
ル)エチル]−S−メチルイソチオウレア4.8gを得
た。中間体(イソチオウレア誘導体)2gをエタノール
20mlに懸濁し、攪拌下メチルアミン40%メタノー
ル溶液10mlを加え、室温3時間攪拌した。反応終了
後、減圧下濃縮し、残渣をエタノール−水より結晶化す
ることにより、N−シアノ−N’−メチル−N”−[2
−ヒドロキシ−2−(p−ブロモフェニル)エチル]グ
アニジン2.6gを得た。 融点 159〜60℃ TLC Rf=0.45 (CHCl3ーMeOH=9:1) 実施例13 エタノール40mlにα−アミノメチル−o−クロロベ
ンジルアルコール3.8gとS,S’−ジメチル−N−
シアノジチオイミノカーボネイト2.9gを溶解し、室
温で3時間攪拌した。反応終了後冷蔵庫に一晩放置し、
析出した結晶を濾取することにより、中間体、N−シア
ノ−N’−[2−ヒドロキシ−2−(o−クロロフェニ
ル)エチル]−S−メチルイソチオウレア4.1gを得
た。中間体(イソチオウレア誘導体)2gをエタノール
20mlに懸濁し、攪拌下エチルアミン70%溶液10
mlを加え、室温3時間攪拌した。反応終了後、減圧下
濃縮し、残渣をエタノール−水より結晶化することによ
り、N−シアノ−N’−エチル−N”−[2−ヒドロキ
シ−2−(o−クロロフェニル)エチル]グアニジン
2.6gを得た。 TLC Rf=0.54 (CHCl3ーMeOH=9:1) 実施例14 エタノール50mlにα−アミノメチル−o−クロロベ
ンジルアルコール6.9gと1,1−ビス(メチルチ
オ)−2−ニトロエチレン6.6gを加え、60〜70
℃で5時間攪拌した。反応終了後、減圧下濃縮し残渣を
エタノール−石油エーテルから結晶化することにより、
中間体、N−[2−ヒドロキシ−2−(o−クロロフェ
ニル)エチル]−1−メチルチオ−2−ニトロエテンア
ミン8.3gを得た。該中間体2gをエタノール20m
lに懸濁し、攪拌下エチルアミン70%溶液10mlを
加え、70℃終夜攪拌した。反応終了後減圧下濃縮し、
残渣をエタノール−水から結晶化することにより、N−
[2−ヒドロキシ−2−(o−クロロフェニル)エチ
ル]−N’−エチル−2−ニトロ−1,1−エテンジア
ミン0.92gを得た。 融点 133〜8℃ TLC Rf=0.52 (CHCl3ーMeOH=9:1)
Example 12 4.3 g of α-aminomethyl-p-bromobenzyl alcohol and 25% of S, S′-dimethyl-N-ethanol were added to 25 ml of ethanol.
2.9 g of cyanodithioiminocarbonate was dissolved and stirred at room temperature for 3 hours. After the reaction, leave it in the refrigerator overnight,
The precipitated crystals were collected by filtration to obtain 4.8 g of an intermediate, N-cyano-N '-[2-hydroxy-2- (p-bromophenyl) ethyl] -S-methylisothiourea. 2 g of the intermediate (isothiourea derivative) was suspended in 20 ml of ethanol, 10 ml of a 40% methanol solution of methylamine was added with stirring, and the mixture was stirred at room temperature for 3 hours. After completion of the reaction, the mixture is concentrated under reduced pressure, and the residue is crystallized from ethanol-water to give N-cyano-N′-methyl-N ″-[2
-Hydroxy-2- (p-bromophenyl) ethyl] guanidine 2.6 g was obtained. Melting point 159-60 ° C TLC Rf = 0.45 (CHCl 3 -MeOH = 9: 1) Example 13 3.8 g of α-aminomethyl-o-chlorobenzyl alcohol and S, S′-dimethyl-N- in 40 ml of ethanol
2.9 g of cyanodithioiminocarbonate was dissolved and stirred at room temperature for 3 hours. After the reaction, leave it in the refrigerator overnight,
The precipitated crystals were collected by filtration to obtain 4.1 g of an intermediate, N-cyano-N '-[2-hydroxy-2- (o-chlorophenyl) ethyl] -S-methylisothiourea. An intermediate (isothiourea derivative) (2 g) was suspended in ethanol (20 ml), and stirred with ethylamine (70% solution 10).
Then, the mixture was stirred at room temperature for 3 hours. After completion of the reaction, the mixture was concentrated under reduced pressure, and the residue was crystallized from ethanol-water to give N-cyano-N'-ethyl-N "-[2-hydroxy-2- (o-chlorophenyl) ethyl] guanidine. TLC Rf = 0.54 (CHCl 3 -MeOH = 9: 1) Example 14 6.9 g of α-aminomethyl-o-chlorobenzyl alcohol and 1,1-bis (methylthio)-were added to 50 ml of ethanol. 6.6 g of 2-nitroethylene was added, and 60 to 70
Stirred at C for 5 hours. After completion of the reaction, the mixture was concentrated under reduced pressure, and the residue was crystallized from ethanol-petroleum ether.
8.3 g of the intermediate, N- [2-hydroxy-2- (o-chlorophenyl) ethyl] -1-methylthio-2-nitroethenamine, were obtained. 2 g of the intermediate is ethanol 20 m
and added 10 ml of a 70% solution of ethylamine with stirring, followed by stirring at 70 ° C. overnight. After completion of the reaction, the mixture is concentrated under reduced pressure.
By crystallizing the residue from ethanol-water, N-
[2-hydroxy-2- (o-chlorophenyl) ethyl] -N'-ethyl-2-nitro-1,1-ethenediamine 0.92 g was obtained. 133-8 ° C TLC Rf = 0.52 (CHCl 3 -MeOH = 9: 1)

【0016】実施例15 N−シアノ−N’−メチル−N”−[2−ヒドロキシ−
2−(p−クロロフェニル)エチル]グアニジン2gを
無水酢酸20mlに懸濁し、攪拌下ピリジン2mlを加
え室温で攪拌した.いったん溶液となったが引き続き攪
拌すると結晶が析出し、一晩冷蔵庫に放置後、析出した
結晶を濾取することにより、N−シアノ−N’−メチル
−N”−[2−アセトキシ−2−(p−クロロフェニ
ル)エチル]グアニジン1.7gを得た。 融点 15
3〜4℃ TLC Rf=0.52 (CHCl3ーMeOH=9:1) 元素分析値 (C1315ClN42として) 計算値 (%) C: 52.98% H: 5.13% N: 19.01% 測定値 (%) C: 53.08% H: 5.17% N: 18.76% 赤外線吸収スペクトル 1735cm-1 (C=O) 実施例16 N−シアノ−N’−エチル−N”−[2−ヒドロキシ−
2−(o−クロロフェニル)エチル]グアニジン2gを
無水酢酸20mlに懸濁し、攪拌下ピリジン2mlを加
え室温で3時間攪拌した。反応終了後減圧下溶媒を留去
し、残渣をエタノール−水から結晶化することにより、
N−シアノ−N’−エチル−N”−[2−アセトキシ−
2−(o−クロロフェニル)エチル]グアニジン1.7
gを得た。 融点 120〜1℃ TLC Rf=0.92 (CHCl3ーMeOH=9:1)
Example 15 N-cyano-N'-methyl-N "-[2-hydroxy-
2- (p-Chlorophenyl) ethyl] guanidine (2 g) was suspended in acetic anhydride (20 ml), pyridine (2 ml) was added with stirring, and the mixture was stirred at room temperature. Once a solution was obtained, crystals were precipitated with continued stirring. After standing in a refrigerator overnight, the precipitated crystals were collected by filtration to give N-cyano-N'-methyl-N "-[2-acetoxy-2-. 1.7 g of (p-chlorophenyl) ethyl] guanidine were obtained, mp 15
3-4 ° C. TLC Rf = 0.52 (CHCl 3 -MeOH = 9: 1) Elemental analysis (as C 13 H 15 ClN 4 O 2 ) Calculated (%) C: 52.98% H: 5.13% N: 19.01 % Measured value (%) C: 53.08% H: 5.17% N: 18.76% Infrared absorption spectrum 1735cm -1 (C = O) Example 16 N-cyano-N'-ethyl-N "-[2-hydroxy-
2- (o-chlorophenyl) ethyl] guanidine (2 g) was suspended in acetic anhydride (20 ml), pyridine (2 ml) was added with stirring, and the mixture was stirred at room temperature for 3 hours. After completion of the reaction, the solvent was distilled off under reduced pressure, and the residue was crystallized from ethanol-water.
N-cyano-N'-ethyl-N "-[2-acetoxy-
2- (o-chlorophenyl) ethyl] guanidine 1.7
g was obtained. Melting point 120-1 ° C TLC Rf = 0.92 (CHCl 3 -MeOH = 9: 1)

【0017】[0017]

【発明の効果】以上の説明から明かな様に、文献未記載
の2−アミノ−1−フェニル−1−エタノール誘導体
は、優れた抗潰瘍作用を有する事が見いだされ、本発明
化合物は消化管における潰瘍の予防、治療に有用であ
る。
As apparent from the above description, it has been found that a 2-amino-1-phenyl-1-ethanol derivative, which has not been described in the literature, has an excellent antiulcer action, and the compound of the present invention has a gastrointestinal tract. It is useful for the prevention and treatment of ulcers in children.

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 化1(式中、R1 は水素原子またはアセ
チル基、R2 は水素原子または低級アルキル基、Xは塩
素原子または臭素原子、YはNR3 基(R3は低級アル
キル基、またはシアノ基を表す。)またはCH−NO2
基を表す。)で表される2−アミノ−1−フェニル−1
−エタノール誘導体。 【化1】
(1) wherein R 1 is a hydrogen atom or an acetyl group, R 2 is a hydrogen atom or a lower alkyl group, X is a chlorine atom or a bromine atom, Y is an NR 3 group (R 3 is a lower alkyl group) , Or a cyano group.) Or CH-NO 2
Represents a group. 2-amino-1-phenyl-1 represented by the formula:
-Ethanol derivatives. Embedded image
JP04109081A 1992-04-03 1992-04-03 2-amino-1-phenyl-1-ethanol derivative Expired - Fee Related JP3081359B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP04109081A JP3081359B2 (en) 1992-04-03 1992-04-03 2-amino-1-phenyl-1-ethanol derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP04109081A JP3081359B2 (en) 1992-04-03 1992-04-03 2-amino-1-phenyl-1-ethanol derivative

Publications (2)

Publication Number Publication Date
JPH05286908A JPH05286908A (en) 1993-11-02
JP3081359B2 true JP3081359B2 (en) 2000-08-28

Family

ID=14501121

Family Applications (1)

Application Number Title Priority Date Filing Date
JP04109081A Expired - Fee Related JP3081359B2 (en) 1992-04-03 1992-04-03 2-amino-1-phenyl-1-ethanol derivative

Country Status (1)

Country Link
JP (1) JP3081359B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101915974B1 (en) * 2017-02-16 2018-11-12 주식회사 디유이엔지 Emergency ladder for electric trains
KR102655806B1 (en) * 2021-08-11 2024-04-09 주식회사 세기엔지니어링 Ladder

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101915974B1 (en) * 2017-02-16 2018-11-12 주식회사 디유이엔지 Emergency ladder for electric trains
KR102655806B1 (en) * 2021-08-11 2024-04-09 주식회사 세기엔지니어링 Ladder

Also Published As

Publication number Publication date
JPH05286908A (en) 1993-11-02

Similar Documents

Publication Publication Date Title
CA1190224A (en) Derivatives of 1,2-diamino-cyclobutene-3,4-dione as potent histamine h.sub.2-antagonists
JPS6343390B2 (en)
SU677655A3 (en) Method of producing n-cyclo-alkymethyl-2-phenylamino-imidazolines-2- or salts thereof
JP3081359B2 (en) 2-amino-1-phenyl-1-ethanol derivative
AU632044B2 (en) Process for preparing a substituted or an unsubstituted 4(5)-(omega-aminoalkyl)imidazole
US4318915A (en) Substituted guandines and methods of preparation thereof
KR0139201B1 (en) Aminobenzenesulfonic acid derivative
US4496573A (en) 1-Pyridylmethyl-3-acyl guanidines
CH634826A5 (en) N-SUBSTITUTED ALPHA-KETOCARBONIC ACID AMIDES.
SE443784B (en) NEW ASSOCIATIONS WITH PHARMACOLOGICAL EFFECT
FI82239C (en) FRAMSTAELLNING AV AMINDERIVAT.
HU188074B (en) Process for the preparation of cimetidin
JPS6360969A (en) Production of imidazole derivative
GB2104071A (en) Furan derivatives
JPS63201165A (en) Cyanoguanidine derivative and production thereof
JP3315146B2 (en) Amino alcohol derivative
NO774407L (en) PROCEDURE FOR PREPARING IMIDAZOLE DERIVATIVES
RU2042671C1 (en) Diketoneimine derivative as an intermediate product for synthesis of ranitidine and method of its synthesis
KR900003882B1 (en) Process for the preparation of compounds with h2 antihistamine activity
JPS6272680A (en) Manufacture of ranitidine or acid addition salt of same
CA1142544A (en) N-cyano-n'-(2-[(4-methyl-5-imidazolyl) methylthio]ethyl) - n"-alkynylguanidines h.sub.2 receptor blocking agents
JPH0528708B2 (en)
KR950002841B1 (en) Process for the preparation of phenyl-guanidine derivatives
RU2032681C1 (en) Method for production of 1-{2-[(5-dimethylaminomethyl-2-furyl)-methylthio] -ethyl}-amino-1-methyl- -amino-2-nitroethylene
JPS63190872A (en) Production of cyanoguanidine derivative

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees